Cargando…
The Paradox of Using Radionuclides To Treat Disease
Autor principal: | Albrecht-Schmitt, Thomas E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439449/ https://www.ncbi.nlm.nih.gov/pubmed/30937365 http://dx.doi.org/10.1021/acscentsci.9b00139 |
Ejemplares similares
-
Improved Quality of Life in Patients Treated with Peptide Radionuclides
por: Traub-Weidinger, T, et al.
Publicado: (2011) -
Tumor Immunotargeting Using Innovative Radionuclides
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2015) -
Use of Infliximab to Treat Paradoxical Tuberculous Meningitis Reactions
por: Marais, Ben J, et al.
Publicado: (2020) -
International Committee for Radionuclide Metrology Symposium on Radionuclide Metrology and its Applications
por: Bortel, G, et al.
Publicado: (1994) -
Delivery of the Radionuclide (131)I Using Cationic Fusogenic Liposomes as Nanocarriers
por: Kolašinac, Rejhana, et al.
Publicado: (2021)